Abstract: A system for providing information to a magnetic card reader. The system comprises an antenna (in one embodiment comprising a multi-purpose antenna or an antenna module) and a microprocessor for applying a differential signal to the antenna. The differential signal represents data stored in a memory segment of the microprocessor or in a memory connected to the microprocessor. The antenna transmits an alternating magnetic field representing the information the alternating magnetic field is responsive to the differential signal and received by the magnetic card reader.

Abstract: A system for providing information to a magnetic card reader. The system comprises an antenna (in one embodiment comprising a multi-purpose antenna or an antenna module) and a microprocessor for applying a differential signal to the antenna. The differential signal represents data stored in a memory segment of the microprocessor or in a memory connected to the microprocessor. The antenna transmits an alternating magnetic field representing the information the alternating magnetic field is responsive to the differential signal and received by the magnetic card reader.

Abstract: A system for providing information to a magnetic card reader. The system comprises an antenna (in one embodiment comprising a multi-purpose antenna or an antenna module) and a microprocessor for applying a differential signal to the antenna. The differential signal represents data stored in a memory segment of the microprocessor or in a memory connected to the microprocessor. The antenna transmits an alternating magnetic field representing the information the alternating magnetic field is responsive to the differential signal and received by the magnetic card reader.

Abstract: There is described a process for the preparation of therapeutically useful pristinamycin II.sub.B sulphone derivatives.Also disclosed are compounds of general formula (I) in which n is equal to 2 in the form of their B isomers, and certain novel compounds of general formula (I) in which n is equal to 2.

Abstract: Cyclopentane derivatives of the formula: ##STR1## wherein R.sup.1 represents hydrogen or a carboxylic acyl group, R.sup.2 represents hydrogen or alkyl of 1 through 12 carbon atoms, and n represents an integer from 4 through 8, are new compounds possessing pharmacological properties, more particularly the production of hypertension and inhibition of gastric acid secretion. They are also useful in the preparation of 10-hydroxyprostaglandins.

Abstract: Cyclopentane derivatives of the formula: ##STR1## (wherein the R symbols represent hydrogen or alkyl, n represents 4 or 6, and the symbols A, B, X and Y have any one of the following combinations: (a) A represents methylene, B represents hydroxymethylene, X represents ethylene and Y represents hydroxymethylene; (b) A represents carbonyl, B represents methylene, X represents ethylene or trans-vinylene and Y represents hydroxymethylene or carbonyl; or (c) A represents hydroxymethylene, B represents methylene, X represents ethylene or trans-vinylene and Y represents hydroxymethylene) are new compounds, possessing pharmacological properties, in particular, the production of hypotension, bronchodilatation, inhibition of gastric acid secretion and stimulation of uterine contraction.

Abstract: Cyclopentane derivatives of the formula: ##STR1## (wherein the R symbols represent hydrogen or alkyl, n represents 4 or 6, and the symbols A, B, X and Y have any one of the following combinations: (a) A represents methylene, B represents hydroxymethylene, X represents ethylene and Y represents hydroxymethylene; (b) A represents carbonyl, B represents methylene, X represents ethylene or trans-vinylene and Y represents hydroxymethylene or carbonyl; or (c) A represents hydroxymethylene, B represents methylene, X represents ethylene or trans-vinylene and Y represents hydroxymethylene) are new compounds, possessing pharmacological properties, in particular, the production of hypotension, bronchodilatation, inhibition of gastric acid secretion and stimulation of uterine contraction.

Abstract: Cyclopentane derivatives of the formula: ##SPC1##(wherein the R symbols represent hydrogen or alkyl, n represents 4 or 6, and the symbols A, B, X and Y have any one of the following combinations: (a) A represents methylene, B represents hydroxymethylene, X represents ethylene and Y represents hydroxymethylene; (b) A represents carbonyl, B represents methylene, X represents ethylene or trans-vinylene and Y represents hydroxymethylene or carbonyl; or (c) A represents hydroxymethylene, B represents methylene, X represents ethylene or trans-vinylene and Y represents hydroxymethylene) are new compounds, possessing pharmacological properties, in particular, the production of hypotension, bronchodilatation, inhibition of gastric acid secretion and stimulation of uterine contraction.